关于
  • English
  • About
    • Management
    • Board of Directors
    • Strategic Advisory Board
    • Our Partners
    • Proprietary Platform Technology
    • About TFChem
  • Programs
    • Pipeline
      • Antiviral
    • Skincare – Dark Spot Correction
    • Skincare – GlycoProteMim™
  • News
    • Sirona News
    • Events
  • Investors
    • Financial Information
    • Financial Reports
    • Investor & Media Kit
    • Newsletter
    • AGM
  • Contact
  • Careers

March 24th, 2015

Sirona Biochem to attend BIO Asia in Tokyo JapanMarch 24-26

March 11th, 2015

Sirona Biochem Announces Successful Development of a Third Skin Lightener with Superior Safety and Efficacy

March 9th, 2015

Sirona Biochem to attend BIO Europe Spring in Paris FranceMarch 9-11Download: SBM BIO EU Presentation March 2015

March 4th, 2015

Sirona Biochem: Positive Preclinical Toxicology Results for its SGLT2 Inhibitor Trigger Milestone Payment from Wanbang Biopharmaceuticals

February 25th, 2015

Sirona Biochem Appoints Dr. Martin Gleave to its Board of Directors

  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 44
  • Next Page »

Archives

  • About
  • TFChem
  • Programs
  • News
  • Investors
  • Contact

© 2025 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
555 Burrard St.
Vancouver, B.C., Canada,V7X1M8

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

© 2025 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
595 Burrard St.
Vancouver, B.C., Canada,V7X 1L4

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

Enter your info below to subscribe to our newsletter:
Loading